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Summary 
 
The psychopathology p factor has emerged from a series of strong empirical studies, largely 
in the adult psychiatry literature. Here some of the recent findings relating to the p factor in 
children and adolescents are considered and the implications for child and adolescent 
psychiatry are discussed. Is it essential to covary for ‘p’ when we study specific domains of 
psychopathology? Do neurodevelopmental conditions make up part of the psychopathology p 
factor? How do we treat the ‘p factor’ in clinics? This editorial considers some of the 
contributions from this issue of Journal of Child Psychology and Psychiatry together with the 
wider literature that speak to these issues.  
 
Editorial 
 
The psychopathology p factor refers to a general latent dimension that is derived from a wide 
range of items measuring adult psychiatric symptoms. It has been proposed that this single 
latent factor can encapsulate individuals’ proclivity to develop all forms of psychopathology 
included within the broad internalising, externalising and thought disorder dimensions (Caspi 
et al., 2014).  
 
While some readers may not find those opening sentences a surprise, for others these 
statements will feel contrary to theories, clinical practices and research findings regarding 
symptom specificity, heterogeneity and subtype clustering within psychopathology.  My 
guess is that there are literally thousands of research papers reporting findings that might feel 
in some way in conflict with the psychopathology p factor model. 
 
The data supporting the psychopathology p factor model are strong, including from 
population-based cohorts and national registers. This editorial will aim to do two things. 
First, drawing on some of the papers in this issue, some of the newest considerations relevant 
to the psychopathology p factor model in childhood and adolescence will be discussed.  
Second, the relevance of the psychopathology p factor to child and adolescence psychiatry 
and thus the readers of this journal will be considered.  
 
The p factor may start early 
We see in the Miller et al article of this issue that a general factor underlying 
psychopathology appears in their data (Miller et al., 2019). They find that factor loadings of 
items are more robust on what they term a general ‘dysregulation profile’ factor than on the 
Child Behavior Checklist subscale factors.  This may seem to be more or less repeating the 
opening paragraph of this article. A key difference, however, is that the participants in Miller 
et al’s study were 36 month old children rather than adults.  As the authors mention, there 
have been only a small number of studies of the factor structure of the ‘dysregulation profile’ 
in young children, some of which are in specially selected samples such as clinically referred 
samples. As such, Miller et al’s study together with other recent work in this area e.g. 
(McElroy, Belsky, Carragher, Fearon, & Patalay, 2018) is important in showing that even 
before children have begun formal schooling or had a huge amount of life experience, 
seemingly specific domains of psychopathology (in Miller et al’s case, internalising, 
externalising and attention problems) fall into a single general factor.  Furthermore, Caspi et 
al (2014) (Caspi et al., 2014) reported that their adult p factor derived from the prospectively-
assessed Dunedin Multidisciplinary Health and Development Study was negatively correlated 
with a general measure of brain integrity at age 3 years. As such, for this journal, we have no 
excuse to dismiss the psychopathology p factor model as something specific to research on 
adults. It’s relevant to children, and therefore this journal’s readers, too. 
 
It’s not yet clear how neurodevelopmental conditions are involved 
Something to note about the Miller et al study is that the sample was enriched with children 
who were younger siblings of children with autism.  And the eagle-eyed reader – especially 
those with an interest in neurodevelopment - will have noticed that the dimensions listed in 
the opening paragraph do not obviously include autism (or a relevant umbrella term such as 
neurodevelopment). Autism spectrum conditions are not mental illnesses and in diagnostic 
manuals they are separated from psychiatric disorders.  Interestingly, in this issue of the 
journal we see that Miller et al did not find that genetic liability for autism was a predictor of 
the dysregulation profile general factor in 36 month olds.  
 
What do we know about autism and the psychopathology p factor model from other samples? 
The Strengths and Difficulties Questionnaire (SDQ) total scale is a commonly used general 
psychopathology measure (see e.g. (Rimvall et al., 2019)). While it includes a subscale of 
peer problems, which is one aspect of social difficulties, the SDQ total does not include 
autistic traits per se. As such, when the p factor or general psychopathology is assessed with 
this measure in children, which is quite often the case, autism or autistic traits are not 
explicitly included.  Some of the most prominent studies on the p factor have not included 
autism thus far, most likely because of their focus on adult psychiatry e.g. (Caspi et al., 2014; 
Lahey, Krueger, Rathouz, Waldman, & Zald, 2017; Pettersson et al., 2018).  It is an 
interesting and arguably still somewhat open question: how is autism connected to the 
psychopathology p factor model?  
 
Some traditional views and characteristics of autism do not sit naturally with the p factor 
model. The uni-dimensional p factor model is associated with a model of psychopathology in 
which symptoms wax and wane, and individuals cycle through different psychiatric 
diagnoses over time (because they have a general vulnerability to psychopathology rather 
than any specific disorder).  Most data and current perspectives on autism view it as a 
condition that does not go away with development (although there are exceptions), does not 
vary particularly in terms of age of onset, and does not morph into other disorders (though 
co-occurrence with other psychopathology is high). It is viewed as a form of 
neurodevelopment rather than a ‘pathology’. We also see autism in genetic syndromes, which 
again are viewed as different to general psychopathology for reasons such as their distinct 
etiology, their permanence across the lifespan and their profile of physical and cognitive 
characteristics.  Of course traditional views sometimes need to be overturned to enable 
progress.  A discussion of how autism is linked to the p factor may help refine thinking about 
the borders and focus of the p factor at different stages of development.  The Miller et al 
study helps to progress our thinking on this front.  
 
The p factor as an essential covariate in studies of specific psychopathology 
Also in this issue, Rimvall et al explore novel questions about how positive psychotic 
experiences such as hallucinations and delusions are associated with health anxiety and 
functional somatic symptoms (Rimvall et al., 2019). In their cohort of 11-12 year olds they 
find significant cross-sectional associations. It is interesting to consider how early traits 
linked to ruminating about bodily sensations might play a part in the early stage development 
of symptoms such as hallucinations that are seen later in psychotic disorders. 
Methodologically, one of the strengths of the study was that the authors checked that the 
association between psychotic experiences and health anxiety and functional somatic 
symptoms held after controlling for general psychopathology (here measured using the 
Strengths and Difficulties Questionnaire).  This is a strength because it offers confidence that 
the associations are specific to psychotic experiences over and above general 
psychopathology.   
 
We see the utility of the p factor for understanding specific aspects of psychopathology 
demonstrated elsewhere in the issue. Manfro et al contribute to a fascinating (and growing) 
literature on youth-onset ADHD, that is, the observation that a subtype of ADHD starts in 
adolescence (Manfro et al., 2019). By exploring general psychopathology scores in childhood 
and adolescence, Manfro et al’s study of trajectories of ADHD in the Brazilian high risk 
cohort reveals that individuals with youth-onset ADHD are already presenting in childhood 
with high p factor scores and more symptoms from other domains of psychopathology. As 
such, the authors hypothesise that late-onset ADHD is a combination of susceptibility to 
general psychopathology coupled with a transition from one domain of psychopathology in 
childhood to another (ADHD) later on. This finding would not have been possible without 
taking ‘p’ into account, and will have almost certainly enriched our understanding of 
adolescent-onset ADHD.  
 
Have we reached a point where controlling for general psychopathology and or the p factor is 
an essential covariate in studies of specific psychopathology? For a long time it has been 
fairly standard to control for general constructs such as IQ and socioeconomic status in 
research. Careful consideration, in any particular study, is essential when considering 
alternative models (Markon, 2019). Certainly the two examples from this issue discussed 
here demonstrate the capacity for involving the p factor or general psychopathology in 
research on specific psychopathology in childhood in order to strengthen confidence in 
findings and to develop new hypotheses.   
 
It’s full steam ahead for genetic research on the p factor  
In behaviour genetics, structural equation models have been used for decades to explore the 
structure of psychopathology and to test models of co-occurrence between disorders or their 
related traits (Lahey et al., 2017). A general genetic factor that influences eight major 
psychiatric disorders using full and half sibling data from Swedish national registers has been 
reported (Pettersson et al., 2018). Complementary to these findings from family data, similar 
conclusions were reached with three other methods that employed measured genotypes 
(Selzam, Coleman, Caspi, Moffitt, & Plomin, 2018). We see the p factor being covaried for 
in genetic studies on specific psychopathology too. Brikell and colleagues tested the degree 
to which the ADHD genomewide polygenic score predicts hyperactivity/impulsivity 
symptoms over and above a general genetic liability towards broad childhood 
psychopathology (Brikell et al., 2018).  Genetic research can speak to some of the 
mechanisms underlying the p factor. 
 
Co-occurrence of symptoms does not necessarily reveal the underlying causal pathway 
between symptoms. Symptoms can co-occur because of correlated causal influences or 
because one symptom itself causes another (though these are not mutually exclusive options). 
In this issue we see how network analysis can inform such issues. Bartels et al employ, 
amongst other things, a Bayesian approach to model directed acyclic graphs of PTSD 
symptoms in children and adolescents (Bartels et al., 2019). They demonstrate which 
symptoms of PTSD are the key drivers of other symptoms within PTSD and thus are able to 
advise, based on their data, which symptoms would be the optimal targets for treatment.  
 
Psychopathology may be general, but treatments can still be specific 
Instead of treating specific symptoms, or disorders, should we treat p? Causation does not 
denote treatment, but does factor structure denote treatment? One might imagine a future 
scenario where patients circulate around a wide range of clinicians trained in specific areas 
who can together support a patient’s individual constellation of p factor symptoms.  Or 
should clinical training start to largely avoid specialisation, and rather put the focus on broad 
expertise across psychopathology? Of course, there could be both specific treatments (and not 
all variance in psychopathology is explained by ‘p’) and general transdiagnostic treatments. 
 
This issue’s highly informative practitioner review focuses on post-traumatic stress disorder 
(PTSD) (Smith, Dalgleish, & Meiser-Stedman, 2019).  This review delivers, amongst many 
other things, a comprehensive overview of the effective treatments for PTSD within 
psychological interventions, which can include trauma-focussed CBT, cognitive therapy for 
PTSD and prolonged exposure. Prolonged exposure can involve imaginal exposure of the 
trauma memory. One wonders to what extent this specific treatment, shown to be effective 
for trauma, can generalise to all other forms of psychopathology. As pointed out elsewhere, 
the evidence for the p factor model is fairly new and thus caution is needed when considering 
possible treatment implications (Caspi & Moffitt, 2018).  One specific constructive 
recommendation is for clinicians, where possible, to assess for an array of symptoms of 
psychopathology beyond the presenting complaint (Lahey et al., 2017). 
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